A Drug Shows Promise In Treating Pancreatic Cancer

Celgene’s drug Abraxane prolonged the lives of patients with advanced pancreatic cancer by almost two months in a clinical trial, but the gains were not as big as expected.

Source: NYT Health - January 23, 2013 Category: Consumer Health News Authors: By ANDREW POLLACK Tags: Pancreatic Cancer Clinical Trials Drugs (Pharmaceuticals) Roche Holding A G RHHBY Other OTC Abraxane Celgene Corporation CELG NASDAQ Abraxis BioScience, Incorporated ABBI NASDAQ Source Type: news